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Table 3
DonorDBY DonorUTY DonorZFY DonorEIF1AY DonorRPS4Y
　 - + P - + P - + P - + P - + P
Recipient - 38 7 0.2 31 13 0.28 55 4 0.29 56 1 >0.99 44 5 0.72
post-HCT + 32 13 　 27 19 　 31 0 　 33 0 　 38 3 　
Abstracts / Biol Blood Marrow Transplant 20 (2014) S45eS56 S55adoptive transfer of HY seropositivity from female donors to
male recipients (Table 3).
Conclusion: Half of female donors were HY-seropositive, but
there were no enough evidence to suggest that the HY
sensitization can predict clinical outcome. In fact, we pro-
vided little evidence of adoptive HY B-cell immunity transfer.
On-going studies will relate female HY sensitization to parity
and age. The absence of adoptive immune transfer might
raise a concern for the efﬁcacy of donor vaccination strate-
gies to augment GVL beneﬁt.52
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The immunosuppressive function of IL10 producing regula-
tory B cells (Bregs) has been shown in several murine models
of inﬂammation and autoimmune disease. However, there is
a paucity of data regarding the existence of an equivalent
regulatory B cell subset in humans and their relevance in the
pathogenesis of chronic graft-versus-host disease (cGVHD)
remains unknown. Here, we explored the regulatory
properties of peripheral blood (PB)-derived human B cell
subsets and their role in cGVHD. Using intracellular cytokine
staining following in vitro stimulation with CD40 ligand, we
showed that the majority of IL-10 producing B cells in
healthy donors are found within the CD24hiCD38hi transi-
tional and CD19+IgM+CD27+ memory B cell subsets. Sort-
puriﬁed IgM memory and transitional B cells suppressed the
proliferation, as well as the release of IFN-g by CD3/CD28
stimulated CD4+ T cells. The inhibitory effect of IgM memory
and transitional B cells on CD4+ T cell proliferation was cell
dose dependent with the highest suppression was observed
at a ratio of 1:1. These data suggest that human PB transi-
tional and IgM memory B cells are endowed with suppres-
sive function. This suppression was mediated partially via
the provision of IL-10, but not TGF-ß, which we assessed by
antibody blockade experiments. Additionally, the suppres-
sive capacity of the B cell subsets was reversed by the addi-
tion of CD80 and CD86 mAbs. Using transwell experiments,
we further determined that the suppressive function of Bregs
is also partly dependent on direct T cell/B cell contact.
Although blockade of IL-10 and IL-10R, CD80 and CD86 andseparation of B cells and T cells by a transwell membrane
individually did not completely reverse the suppressive
ability of transitional and IgMmemory B cells, a combination
of these factors sufﬁciently reversed the ability of Breg
subsets to suppress CD4+ Tcell proliferation. Thus, analogous
to murine experimental models the suppressive effect of
human Breg cells involves both the release of IL-10 and
co-receptor interaction. Additionally, Breg cells isolated from
patients with cGVHD were refractory to CD40 stimulation
and produced less IL-10 when compared to patients without
cGVHD post-SCT and healthy controls. Likewise, the absolute
number of IL-10 producing B cells was signiﬁcantly lower in
cGvHD patients compared to patients without cGVHD and
healthy controls (p¼0.007), supporting the existence of both
a qualitative and quantitative defect in IL-10 producing
B cells in cGvHD.
Our combined studies provide important new data deﬁning
the phenotype of B cell populations enriched in regulatory
B cells in healthy humans and provide evidence of altered
cellular function within such cells that may impact a broad
range of deﬁciencies in immune regulatory cell function in
cGvHD post transplant patients.
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Background: Commensal gut microbiota have been im-
plicated in initiating and perpetuating intestinal graft versus
host disease (iGVHD), but its role remains controversial. Recent
murine studies have shown that iGVHD results in destruction
of intestinal mucosal immune defenses resulting in expansion
of pro-inﬂammatory bacteria (Enterobacteriaceae, ENTERO),
and by prophylactically treatingmicewith oral antibiotics that
suppress growth of ENTERO, iGVHD was signiﬁcantly
improved1. Furthermore, small-chain fatty acid producing
(SCFA) Clostridia have been shown to induce colonic Treg cells,
to dampen gut inﬂammation, and to cure IBD in mice2. But
theseﬁndingshavenot beenobservedor replicated inhumans.
Methods: Stool samples were collected on a weekly basis
from pediatric allogeneic BMT patients from 7/26/11 e 9/30/
13. Bacterial and fungal gDNA was isolated from fecal spec-
imens. Amplicons for 16S rRNAV4 variable region and fungal
ITS region were generated and sequenced on Roche 454
GS-FLX sequencer and Illumina HiSeq2000 respectively.
Sequencing data was analyzed using QIIME software. The
abundance of speciﬁc intestinal bacterial groups was deter-
mined by qPCR using group-speciﬁc 16S rRNA gene primers.
For patients undergoing intestinal biopsy for suspicion of
iGVHD (abdominal pain, diarrhea), additional pieces of
intestine were obtained for transcription proﬁling experi-
ments using Illumina HumanHT12 V4 Expression BeadChips.
Clinical characteristics (i.e. conditioning regimens, speciﬁc
antibiotic use, immunosuppression, etc) were recorded.
